Kim Forest Enterprise (TPE:6645) won a tender to supply whole genome sequencing assay kits to a national hospital in Taiwan under a contract worth NT$110 million, according to a Wednesday Taiwan Exchange filing.
Shares slid about 2% in Thursday's late morning trade.
The contract runs from June 10, 2026, to Dec. 31, 2028.
Kim Forest said the deal is expected to expand its business operations and boost revenue.